Human Serum Complement C3 and Factor H in the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count
Human Serum Complement C3 and Factor H in the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count
复制标题
DOI:
10.1111/j.1600-0897.2009.00731.x
复制
发表时间:
2009-10-01
影响因子:
3.6
通讯作者:
Ozener, Cetin
中科院分区:
文献类型:
--
作者:
Ari, Elif;Yilmaz, Yusuf;Ozener, Cetin
ProblemHemolysis, elevated liver enzymes, and low platelet count syndrome (HELLP syndrome) is a life-threatening variant of severe pre-eclampsia in pregnant women. The complement system may play a role in the pathogenesis of this condition. We sought to determine serum complement 3 (C3) levels and its regulatory protein complement factor H (FH) in the HELLP syndrome.Method of studyTwenty-two pre-eclamptic patients with HELLP syndrome (mean age: 27.8 +/- 6.2 years), 21 pre-eclamptic patients without HELLP syndrome (mean age: 27.5 +/- 6.8 years) and 24 normotensive, healthy pregnant women (mean age: 26.1 +/- 4.4 years) were included in this study. Serum concentrations of C3 and FH were measured in all participants.ResultsConcentrations of C3 and FH did not differ significantly between the study groups. In patients with the HELLP syndrome, FH levels were positively associated with platelet count.ConclusionThese findings did not support a major role of complement activation in the HELLP syndrome. In patients with HELLP, lower levels of FH are correlated with a reduced platelet count.